ATS medical (atsi} Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATS medical (atsi}

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: George A. Dubrowski who wrote (6)	11/4/1996 2:56:00 PM
From: Mark Cahill	of 63

I received a copy of a security analyst's update report on ATS Medical. It does not add much to ATS's recent quarterly report. The securities company believes "the intrinsic value of ATS Medical is $11.75 per share. With the recent, and unexplained, slide in the price..., we believe that the market has presented investors with an opportunity to invest in a developmental-stage medical device company whose principal product is currently approved in all major markets of the world except the U.S...With upside potential of nearly 77% from the current level of $6.625 shares of ATS Medical are attractively priced..." Seems a statement of the obvious to me. What I want to know is why the price decreased..."unexplained" is not what security companies should be telling us. And "more sellers than buyers" is not the sarcastic answer I am looking for. All in all, not a very good update from the research dept.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next